Sales Ended

Capital Cell Demo Day, London

Event Information

Share this event

Date and Time

Location

Location

The Park Room

Rydges Kensington London

61 Gloucester Road

London

SW7 4PE

United Kingdom

View Map

Friends Who Are Going
Event description

Description

Following Capital Cell's success in Spain, we're excited to be launching our brand new equity investment platform in the UK. As part of our UK launch, you're invited to attend our first London based Demo Day - a pitch event showcasing innovative life science companies and their novel research and development projects.


AN EVENING OF PITCHES, ROUNTABLES AND NETWORKING

Discover new investment opportunities in the life science sector, and spend valuable time networking with the entrepreneurs and scientists themselves.

6:00pm Registration and Welcome Talk by Daniel Oliver, CEO

6:30pm Company investment pitches

7:30pm Roundtables and Q&A session

8:00pm Open networking and refreshments

9:00pm End


A SELECTION OF LIFE SCIENCE COMPANIES, INCLUDING:

NOVARIX

A market-ready medical device which helps preserve the health of veins via new, more accurate detection technology, with a very promising target market of over 1million locations, worldwide.

BEAMLINE

A bedside diagnostic device that accurately distinguishes healthy/ benign biopsies in minutes. It removes the stress of waiting weeks for test results from patients, and will save the NHS millions of pounds per year.

LIFT BIOSCIENCES

With a 100% cure rate of sarcoma and prostate cancer in mouse models, Leukocyte Infusion Therapy (LIfT) is a stem cell derived immune-oncology cell therapy, suitable for all solid tumor types.

FORREST INNOVATIONS

A project concerned with the natural vector control of mosquito-borne diseases, through non-GM sterile insect production and release. The company founder and CEO co-founded Beeologics, acquired by Monsanto in 2011.

COMBAT MEDICAL

A heated drug delivery system which enhances the delivery of existing and new drugs to improve efficacy in the treatment of a range of cancers; with the potential to improve the treatment of over a million cancer sufferers worldwide every year.

ANTIKOR

A revolutionary solid cancer therapy based on a novel type of Antibody Drug Conjugtes (ADC). The Fragment Drug conjugate (FDC) greatly improves the delivery of drug payload in cancer cells.

Date and Time

Location

The Park Room

Rydges Kensington London

61 Gloucester Road

London

SW7 4PE

United Kingdom

View Map

Save This Event

Event Saved